![]() | ![]() | ![]() | ![]() | ![]() | Six Month Ended June 30, 2004 | Six Month Ended June 30, 2004 (as restated) |
|---|---|---|---|---|---|---|
| Cash flows from operating activities |
|
|
||||
| Net cash used in operating activities |
-16,757,000
|
-49,452,000
|
||||
| Net income (loss) |
14,021,000
|
-4,295,000
|
||||
| Depreciation and amortization |
20,222,000
|
21,951,000
|
||||
| Asset impairment charges |
201,000
|
249,000
|
||||
| Gain on sale of building |
-896,000
|
|
||||
| Cash used in discontinued operations |
-493,000
|
-977,000
|
||||
| Changes in other assets and liabilities, net of non-cash transactions |
-49,812,000
|
-66,380,000
|
||||
| Cash flows from investing activities: |
|
|
||||
| Net cash used in investing activities |
-3,849,000
|
-12,255,000
|
||||
| Purchase of property, plant and equipment |
-11,079,000
|
-13,248,000
|
||||
| Proceeds from the sale of building |
6,731,000
|
|
||||
| Other |
499,000
|
993,000
|
||||
| Cash flows from financing activities: |
|
|
||||
| Net cash provided by financing activities |
18,454,000
|
46,852,000
|
||||
| Proceeds from borrowings |
101,571,000
|
144,078,000
|
||||
| Payment of Debt |
-91,801,000
|
-94,289,000
|
||||
| Proceeds from stock options exercised |
12,481,000
|
759,000
|
||||
| Payment of dividends |
-3,797,000
|
-3,696,000
|
||||
| Net decrease in cash and cash equivalents |
-2,152,000
|
-14,855,000
|
||||
| Cash and Cash Equivalents--end of period |
14,858,000
|
18,026,000
|
||||
| Cash and Cash Equivalents--beginning of period |
17,010,000
|
32,881,000
|
||||
These sample instance documents and taxonomies were developed as a 'test' of the USGAAP XBRL taxonomy and certain software tools. Because the taxonomy and tools are not yet complete, the instance documents and taxonomies are not 'full'-, accurate-, representations.